name,oldname,accession,pdbid,modified,comment,year,doi
App1Ba1,XaxA,CBJ91797.1,6GY8,No,,2018,10.7554/eLife.38017
App1Ba1,XaxA,CBJ91797.1,6GY6,No,In complex with App2Ba1 (XaxB),2018,10.7554/eLife.38017
App1Ca1,YaxA,6EK7_A,6EK7,No,,2018,10.1038/s41467-018-04139-2
App1Ca1,YaxA,6EK7_A,6EL1,No,,2018,10.1038/s41467-018-04139-2
App2Aa1,PaxB,WP_046395991,6EK4,No,,2018,10.1038/s41467-018-04139-2
App2Ba1,XaxB,CBJ91798.1,6GY7,No,,2018,10.7554/eLife.38017
App2Ba1,XaxB,CBJ91798.1,6GY6,No,In Complex with App1Ba1 (XaxA),2018,10.7554/eLife.38017
App3Aa1,YaxB,WP_011816274,6EL1,No,,2018,10.1038/s41467-018-04139-2
App6Aa1,Cry6Aa1,AAA22357,5GHE,No,"Activated, major chain",2016,10.1016/j.bbrc.2016.07.002
App6Aa1,Cry6Aa1,AAA22357,5KUC,No,Trypsin activated,2016,10.1186/s12915-016-0295-9
App6Aa1,Cry6Aa1,AAA22357,5KUD,No,,2016,10.1186/s12915-016-0295-9
App6Aa2,Cry6Aa2,AAM46849,5GHE,No,"Activated, major chain",2016,10.1016/j.bbrc.2016.07.002
App6Aa2,Cry6Aa2,AAM46849,5KUC,No,Trypsin activated,2016,10.1186/s12915-016-0295-9
App6Aa2,Cry6Aa2,AAM46849,5KUD,No,,2016,10.1186/s12915-016-0295-9
Cry chimera,,6OWK_A,6OWK,Yes,"Chimeric protein (named ""Cry1B tryptic core variant"" in publication)",2019,10.1128/AEM.00579-19
Cry Chimera,,6DJ4_A,6DJ4,Yes,"Chimera of Cry1Ab, 1Ac, 1F: does not associate with a single database entry.  Described as Cry1A.105",2018,10.1016/j.yrtph.2018.09.003
Cry variant,,6WPC_A,6WPC,Yes,"Non-natural Cry variant named Cry1A.2, tryptic core",2021,unpublished
Cry1Aa6,Cry1Aa6,AAA86265,1CIY,No,,1997,10.1006/jmbi.1995.0630
Cry1Ac4,Cry1Ac4,AAA73077,4W8J,yes,Full-length (133 kDa) protoxin: 14x Cys-Ser and F462V mutant of Cry1Ac4,2014,10.1002/pro.2536
Cry1Ac7,Cry1Ac7,AAB46989,4ARX,No,,2013,10.1107/s090744490101040x 
Cry1Ac7,Cry1Ac7,AAB46989,4ARY,No,Bound to GalNAc,2013,10.1107/s090744490101040x 
Cry1Ac8,Cry1Ac8,AAC44841,4ARX,No,,2013,10.1107/s090744490101040x 
Cry1Ac8,Cry1Ac8,AAC44841,4ARY,No,Bound to GalNAc,2013,10.1107/s090744490101040x 
Cry1Da1,Cry1Da1,CAA38099,6OVB,Yes,"V108C, E128C, S282V, Y316S, I368P mutant of Cry1Da1",2019,10.1128/AEM.00579-19
Cry2Aa1,Cry2Aa1,AAA22335,1I5P,No,,2001,10.1016/s0969-2126(01)00601-3
Cry2Aa10,Cry2Aa10,AF433645,1I5P,No,,2001,10.1016/s0969-2126(01)00601-3
Cry2Aa19,Cry2Aa19,AYN72228,1I5P,No,,2001,10.1016/s0969-2126(01)00601-3
Cry2Aa2,Cry2Aa2,AAA83516,1I5P,No,,2001,10.1016/s0969-2126(01)00601-3
Cry2Aa20,Cry2Aa20,AYN72229,1I5P,No,,2001,10.1016/s0969-2126(01)00601-3
Cry2Aa21,Cry2Aa21,AYN72230,1I5P,No,,2001,10.1016/s0969-2126(01)00601-3
Cry2Aa9,Cry2Aa9,AAO13750,1I5P,No,,2001,10.1016/s0969-2126(01)00601-3
Cry3Aa12,Cry3Aa12,ABY49136,1DLC,No,,1994,10.1038/353815a0
Cry3Aa12,Cry3Aa12,ABY49136,"4QX0,4QX1,4QX2,4QX3",No,,2014,10.1073/pnas.1413456111
Cry3Aa12,Cry3Aa12,ABY49136,6LFP,No,Co-crystalised in vivo with an entrapped recombinant lipase,2020,10.1021/jacs.9b13462
Cry3Aa12,Cry3Aa12,ABY49136,7EAR,Yes,"Positive charged mutant with multiple mutations (N391K, N395K, E423K, Q430K, D432K, E433K, T436K, T461K, D462K, E463K, E466K)",2021,10.1016/j.biomaterials.2021.120759
Cry3Aa2,Cry3Aa2,AAA22541,1DLC,No,,1994,10.1038/353815a0
Cry3Aa2,Cry3Aa2,AAA22541,"4QX0,4QX1,4QX2,4QX3",No,,2014,10.1073/pnas.1413456111
Cry3Aa2,Cry3Aa2,AAA22541,6LFP,No,Co-crystalised in vivo with an entrapped recombinant lipase,2020,10.1021/jacs.9b13462
Cry3Aa2,Cry3Aa2,AAA22541,7EAR,Yes,"Positive charged mutant with multiple mutations (N391K, N395K, E423K, Q430K, D432K, E433K, T436K, T461K, D462K, E463K, E466K)",2021,10.1016/j.biomaterials.2021.120759
Cry3Aa3,Cry3Aa3,CAA68482,1DLC,No,,1994,10.1038/353815a0
Cry3Aa3,Cry3Aa3,CAA68482,"4QX0,4QX1,4QX2,4QX3",No,,2014,10.1073/pnas.1413456111
Cry3Aa3,Cry3Aa3,CAA68482,6LFP,No,Co-crystalised in vivo with an entrapped recombinant lipase,2020,10.1021/jacs.9b13462
Cry3Aa3,Cry3Aa3,CAA68482,7EAR,Yes,"Positive charged mutant with multiple mutations (N391K, N395K, E423K, Q430K, D432K, E433K, T436K, T461K, D462K, E463K, E466K)",2021,10.1016/j.biomaterials.2021.120759
Cry3Aa5,Cry3Aa5,AAA50255,1DLC,No,,1994,10.1038/353815a0
Cry3Aa5,Cry3Aa5,AAA50255,"4QX0,4QX1,4QX2,4QX3",No,,2014,10.1073/pnas.1413456111
Cry3Aa5,Cry3Aa5,AAA50255,6LFP,No,Co-crystalised in vivo with an entrapped recombinant lipase,2020,10.1021/jacs.9b13462
Cry3Aa5,Cry3Aa5,AAA50255,7EAR,Yes,"Positive charged mutant with multiple mutations (N391K, N395K, E423K, Q430K, D432K, E433K, T436K, T461K, D462K, E463K, E466K)",2021,10.1016/j.biomaterials.2021.120759
Cry3Aa6,Cry3Aa6,AAC43266,1DLC,No,,1994,10.1038/353815a0
Cry3Aa6,Cry3Aa6,AAC43266,"4QX0,4QX1,4QX2,4QX3",No,,2014,10.1073/pnas.1413456111
Cry3Aa6,Cry3Aa6,AAC43266,6LFP,No,Co-crystalised in vivo with an entrapped recombinant lipase,2020,10.1021/jacs.9b13462
Cry3Aa6,Cry3Aa6,AAC43266,7EAR,Yes,"Positive charged mutant with multiple mutations (N391K, N395K, E423K, Q430K, D432K, E433K, T436K, T461K, D462K, E463K, E466K)",2021,10.1016/j.biomaterials.2021.120759
Cry3Bb1,Cry3Bb1,AAA22334,1JI6,No,,2001,10.1107/s0907444901008186
Cry4Aa1,Cry4Aa1,CAA68485,2C9K,No,,2006,10.1128/JB.188.9.3391-3401.2006
Cry4Ba1,Cry4Ba1,CAA30312,1W99,No,,2005,10.1016/j.jmb.2005.02.013
Cry4Ba1,Cry4Ba1,CAA30312,4MOA,Yes,R203Q mutant,2014,10.1074/jbc.M114.627554
Cry5Ba1,Cry5Ba1,AAA68598,4D8M,No,,2012,10.1021/bi301386q
Cry7Ca1,Cry7Ca1,ABR67863,5ZI1,Yes,,2018,10.1002/pro.3561
Cry8Ea1,Cry8Ea1,AY329081,3EB7,No,,2008,10.1016/j.jsb.2009.07.004
Cyt1Aa1,Cyt1Aa1,CAA26943,6T14,No,pH7,2020,10.1038/s41467-020-14894-w
Cyt1Aa1,Cyt1Aa1,CAA26943,6T19,No,,2020,10.1038/s41467-020-14894-w
Cyt1Aa1,Cyt1Aa1,CAA26943,6T1A,No,pH10,2020,10.1038/s41467-020-14894-w
Cyt1Aa1,Cyt1Aa1,CAA26943,3RON,No,,2011,10.1016/j.jmb.2011.09.021
Cyt1Aa1,Cyt1Aa1,CAA26943,6T1C,Yes,Cys7Ser mutant,2020,10.1038/s41467-020-14894-w
Cyt1Aa2,Cyt1Aa2,CAA27868,3RON,No,,2011,10.1016/j.jmb.2011.09.021
Cyt1Aa2,Cyt1Aa2,CAA27868,6T14,Yes,pH7,2020,10.1038/s41467-020-14894-w
Cyt1Aa2,Cyt1Aa2,CAA27868,6T19,No,,2020,10.1038/s41467-020-14894-w
Cyt1Aa2,Cyt1Aa2,CAA27868,6T1A,No,pH10,2020,10.1038/s41467-020-14894-w
Cyt1Aa2,Cyt1Aa2,CAA27868,6T1C,yes,Cys7Ser mutant,2020,10.1038/s41467-020-14894-w
Cyt1Aa5,Cyt1Aa5,CAD30079,3RON,No,,2011,10.1016/j.jmb.2011.09.021
Cyt1Aa5,Cyt1Aa5,CAD30079,6T14,yes,pH7,2020,10.1038/s41467-020-14894-w
Cyt1Aa5,Cyt1Aa5,CAD30079,6T19,No,,2020,10.1038/s41467-020-14894-w
Cyt1Aa5,Cyt1Aa5,CAD30079,6T1A,No,pH10,2020,10.1038/s41467-020-14894-w
Cyt1Aa5,Cyt1Aa5,CAD30079,6T1C,yes,Cys7Ser mutant,2020,10.1038/s41467-020-14894-w
Cyt2Aa1,Cyt2Aa1,CAA78519,1CBY,No,,1996,10.1006/jmbi.1996.0152
Cyt2Aa2,Cyt2Aa2,CAA78519,1CBY,No,,1996,10.1006/jmbi.1996.0152
Cyt2Aa4,Cyt2Aa4,AAM09651,1CBY,No,,1996,10.1006/jmbi.1996.0152
Cyt2Ba10,Cyt2Ba10,ACX54358,2RCI,No,,2008,10.1016/j.jmb.2011.09.021
Cyt2Ba11,Cyt2Ba11,ACX54359,2RCI,No,,2008,10.1016/j.jmb.2011.09.021
Cyt2Ba12,Cyt2Ba12,ACX54360,2RCI,No,,2008,10.1016/j.jmb.2011.09.021
Cyt2Ba13,Cyt2Ba13,ACI42304,2RCI,No,,2008,10.1016/j.jmb.2011.09.021
Cyt2Ba14,Cyt2Ba14,ACI42305,2RCI,No,,2008,10.1016/j.jmb.2011.09.021
Cyt2Ba15,Cyt2Ba15,AEL29854,2RCI,No,,2008,10.1016/j.jmb.2011.09.021
Cyt2Ba7,Cyt2Ba7,AAF37222,2RCI,No,,2008,10.1016/j.jmb.2011.09.021
Cyt2Ba9,Cyt2Ba9,CAD30094,2RCI,No,,2008,10.1016/j.jmb.2011.09.021
Cyt5Aa1,Cyt5Aa1,WP_013316150,2MLW,No,,2015,10.1038/srep08791
Gpp34Ab1,Cry34Ab1,AAG41671,4JOX,No,,2013,10.1371/journal.pone.0112555
Mpf1Aa1,PluMACPF,2QP2_A,2QP2,No,,2007,10.1126/science.1144706
Mpf3Aa1,GNIP1Aa,AML23188,6FBM,No,,2019,10.1073/pnas.1815547116
Mpp23Aa1,Cry23Aa1,AAF76375,4RHZ,No,Co-crystalised with Xpp37Aa1,2014,unpublished
Mpp45Aa1,Cry45Aa1,BAD22577,2D42,No,,2006,10.1002/prot.20843
Mpp46Aa1,Cry46Aa1,BAC79010,2ZTB,No,,2009,10.1016/j.jmb.2008.12.002
Mpp51Aa1,Cry51Aa1,ABI14444,4PKM,No,,2015,10.1016/j.bbrc.2015.04.068
Mpp51Aa2,Cry51Aa2,BAD22577,5HD2,No,,2016,10.1038/ncomms12213
Mpp75Aa1,Cry75Aa1,ASY04853,7ML9,No,,2021,unpublished
Mtx1Aa1,Mtx1,AAA22601,2VSE,No,,2008,10.1016/j.jmb.2008.05.067
Mtx1Aa1,Mtx1,AAA22601,2VSA,No,,2008,10.1016/j.jmb.2008.05.067
Mtx1Aa1,Mtx1,AAA22601,2CB6,yes,Catalytic domain E195Q mutant,2006,10.1016/j.jmb.2006.01.025
Mtx1Aa1,Mtx1,AAA22601,2CB4,yes,Catalytic domain E195Q mutant,2006,10.1016/j.jmb.2006.01.025
Pra2Aa1,PirA,3X0T_A,3X0T,No,,2015,10.1073/pnas.1503129112
Prb2Aa1,PirB,3X0U_A,3X0U,No,,2015,10.1073/pnas.1503129112
Tpp1Aa2,BinA2,WP_012291791,5FOY,No,"Natural co-crystal with Tpp2Aa2, pH7",2016,10.1038/nature19825
Tpp1Aa2,BinA2,WP_012291791,5FOZ,No,"Natural co-crystal with Tpp2Aa2, pH10",2016,10.1038/nature19825
Tpp1Aa2,BinA2,WP_012291791,5G37,No,"Natural co-crystal with Tpp2Aa2, pH5",2016,10.1038/nature19825
Tpp2Aa2,BinB2,WP_012291792,5FOY,No,"Natural co-crystal with Tpp1Aa2, pH7",2016,10.1038/nature19825
Tpp2Aa2,BinB2,WP_012291792,5FOZ,No,"Natural co-crystal with Tpp1Aa2, pH10",2016,10.1038/nature19825
Tpp2Aa2,BinB2,WP_012291792,5G37,No,"Natural co-crystal with Tpp1Aa2, pH5",2016,10.1038/nature19825
Tpp2Aa3,BinB3,WP_036216621,3WA1,No,,2014,10.1002/prot.24636
Tpp35Ab1,Cry35Ab1,AAG41672,4JP0,No,,2014,10.1371/journal.pone.0112555
Vip3Aa10,Vip3Aa11,AAR36859,6VLS,No,"Trypsin activated fragment: truncated, non-active",2020,10.3390/toxins12070438
Vip3Aa11,Vip3Aa11,AAR36859,6VLS,No,"Trypsin activated fragment: truncated, non-active",2020,10.3390/toxins12070438
Vip3Aa12,Vip3Aa11,AAR36860,6VLS,No,"Trypsin activated fragment: truncated, non-active",2021,10.3390/toxins12070439
Vip3Aa15,Vip3Aa11,AAR36861,6VLS,No,"Trypsin activated fragment: truncated, non-active",2022,10.3390/toxins12070440
Vip3Aa16,Vip3Aa16,AAW65132,6TFJ,No,,2020,10.1038/s41467-020-17758-5
Vip3Aa16,Vip3Aa16,AAW65132,6TFK,No,trypsin activated,2020,10.1038/s41467-020-17758-5
Vip3Aa21,Vip3Aa11,AAR36862,6VLS,No,"Trypsin activated fragment: truncated, non-active",2023,10.3390/toxins12070441
Vip3Aa33,Vip3Aa11,AAR36863,6VLS,No,"Trypsin activated fragment: truncated, non-active",2024,10.3390/toxins12070442
Vip3Aa34,Vip3Aa11,AAR36864,6VLS,No,"Trypsin activated fragment: truncated, non-active",2025,10.3390/toxins12070443
Vip3Aa36,Vip3Aa11,AAR36865,6VLS,No,"Trypsin activated fragment: truncated, non-active",2026,10.3390/toxins12070444
Vip3Aa37,Vip3Aa11,AAR36866,6VLS,No,"Trypsin activated fragment: truncated, non-active",2027,10.3390/toxins12070445
Vip3Aa43,Vip3Aa11,AAR36867,6VLS,No,"Trypsin activated fragment: truncated, non-active",2028,10.3390/toxins12070446
Vip3Bc1,Vip3Bc1,ATD53733,6V1V,yes,Multiple mutant form,2019,10.1002/pro.3803
Vip3Bc1,Vip3Bc1,ATD53733,6YRF,No,,2020,10.1038/s41467-021-23146-4
Vip3Bc1,Vip3Bc1,ATD53733,6YRF,No,Trypsin activated (residues at tip of pore region constructed by homology modelling),2020,10.1038/s41467-021-23146-4
Vip3Bc1,Vip3Bc1,ATD53733,7NTX,No,Trypsin activated,2020,10.1038/s41467-021-23146-4
Vip3Bc2,Vip3Bc2,ATD53733,6V1V,yes,Multiple mutant form,2019,10.1002/pro.3803
Vip3Bc2,Vip3Bc2,ATD53733,6YRF,No,,2020,10.1038/s41467-021-23146-4
Vip3Bc2,Vip3Bc2,ATD53733,6YRF,No,Trypsin activated (residues at tip of pore region constructed by homology modelling),2020,10.1038/s41467-021-23146-4
Vip3Bc2,Vip3Bc2,ATD53733,7NTX,No,Trypsin activated,2020,10.1038/s41467-021-23146-4
Vpa2Aa3,Vip2Aa3,AEH05931,1QS1,No,,1999,10.1038/13300
Vpa2Aa3,Vip2Aa3,AEH05931,1QS2,No,With bound NAD,1999,10.1038/13300
Vpb1Ac1,Vip1Ac1,AEH05932,6SMS,No,,2021,unpublished
Vpb4Da1,Vip4Da1,AZJ95709,7MJR,No,,2021,unpublished
Vpb4Da2,Vip4Da2,AZJ95709,7MJR,No,,2021,unpublished
Xpp37Aa1,Cry37Aa1,AAF76376,4RHZ,No,Co-crystalised with Mpp23Aa1,2015,unpublished